• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经调节素 U,代谢紊乱中的关键分子。

Neuromedin U, a Key Molecule in Metabolic Disorders.

机构信息

Department of Neurophysiology, Faculty of Medicine, Oita University, Oita 870-5593, Japan.

出版信息

Int J Mol Sci. 2021 Apr 19;22(8):4238. doi: 10.3390/ijms22084238.

DOI:10.3390/ijms22084238
PMID:33921859
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8074168/
Abstract

Obesity is now a public health concern. The leading cause of obesity is an energy imbalance between ingested and expended calories. The mechanisms of feeding behavior and energy metabolism are regulated by a complex of various kinds of molecules, including anorexigenic and orexigenic neuropeptides. One of these neuropeptides, neuromedin U (NMU), was isolated in the 1980s, and its specific receptors, NMUR1 and NMUR2, were defined in 2000. A series of subsequent studies has revealed many of the physiological roles of the NMU system, including in feeding behavior, energy expenditure, stress responses, circadian rhythmicity, and inflammation. Particularly over the past decades, many reports have indicated that the NMU system plays an essential and direct role in regulating body weight, feeding behavior, energy metabolism, and insulin secretion, which are tightly linked to obesity pathophysiology. Furthermore, another ligand of NMU receptors, NMS (neuromedin S), was identified in 2005. NMS has physiological functions similar to those of NMU. This review summarizes recent observations of the NMU system in relation to the pathophysiology of obesity in both the central nervous systems and the peripheral tissues.

摘要

肥胖症现在是一个公共卫生关注点。肥胖的主要原因是摄入和消耗的卡路里之间的能量失衡。摄食行为和能量代谢的机制受到包括厌食性和食欲性神经肽在内的各种分子的复杂调节。这些神经肽之一,神经调节素 U(NMU)于 20 世纪 80 年代被分离出来,其特定的受体 NMUR1 和 NMUR2 于 2000 年被定义。随后的一系列研究揭示了 NMU 系统的许多生理作用,包括摄食行为、能量消耗、应激反应、昼夜节律和炎症。特别是在过去几十年中,许多报告表明,NMU 系统在调节体重、摄食行为、能量代谢和胰岛素分泌方面发挥着重要而直接的作用,这些都与肥胖的病理生理学密切相关。此外,NMU 受体的另一种配体,NMS(神经调节素 S)于 2005 年被鉴定出来。NMS 具有与 NMU 相似的生理功能。本综述总结了 NMU 系统在中枢神经系统和外周组织中与肥胖病理生理学相关的最新观察结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6cd/8074168/e584f280cd29/ijms-22-04238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6cd/8074168/4cb7689a8e5f/ijms-22-04238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6cd/8074168/e584f280cd29/ijms-22-04238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6cd/8074168/4cb7689a8e5f/ijms-22-04238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6cd/8074168/e584f280cd29/ijms-22-04238-g002.jpg

相似文献

1
Neuromedin U, a Key Molecule in Metabolic Disorders.神经调节素 U,代谢紊乱中的关键分子。
Int J Mol Sci. 2021 Apr 19;22(8):4238. doi: 10.3390/ijms22084238.
2
The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).中枢给予神经介素U和神经介素S的抗肥胖作用主要由神经介素U受体2(NMUR2)介导。
Endocrinology. 2009 Jul;150(7):3101-9. doi: 10.1210/en.2008-1772. Epub 2009 Mar 26.
3
Neuromedins NMU and NMS: An Updated Overview of Their Functions.神经调节素 NMU 和 NMS:功能的最新概述。
Front Endocrinol (Lausanne). 2021 Jul 1;12:713961. doi: 10.3389/fendo.2021.713961. eCollection 2021.
4
Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.外周给予神经调节素 U 受体 2 选择性激动剂对肥胖小鼠摄食量和体重的影响。
Int J Obes (Lond). 2017 Dec;41(12):1790-1797. doi: 10.1038/ijo.2017.176. Epub 2017 Jul 31.
5
Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens.鸡中神经调节素 U(NMU)、神经调节素 S(NMS)及其受体(NMUR1、NMUR2)的特性。
Peptides. 2018 Mar;101:69-81. doi: 10.1016/j.peptides.2017.12.022. Epub 2017 Dec 27.
6
Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway.神经介素U具有一种独立于瘦素信号通路的新型厌食效应。
Nat Med. 2004 Oct;10(10):1067-73. doi: 10.1038/nm1106. Epub 2004 Sep 26.
7
Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.神经调节素 U 和结构相关肽神经调节素 S 的新兴药理学和生理学。
Br J Pharmacol. 2009 Sep;158(1):87-103. doi: 10.1111/j.1476-5381.2009.00252.x. Epub 2009 Jun 10.
8
[The discovery of neuromedin U and its pivotal role in the central regulation of energy homeostasis].[神经介素U的发现及其在能量稳态中枢调节中的关键作用]
Postepy Hig Med Dosw (Online). 2012 Apr 16;66:196-203. doi: 10.5604/17322693.991448.
9
Effects of peripherally administered neuromedin U on energy and glucose homeostasis.外周给予神经调节素 U 对能量和葡萄糖稳态的影响。
Endocrinology. 2011 Jul;152(7):2644-54. doi: 10.1210/en.2010-1463. Epub 2011 May 17.
10
Cloning and expression patterns of neuromedin U and its receptors in pigs.猪的神经调节素 U 及其受体的克隆与表达模式。
Neuropeptides. 2017 Aug;64:47-60. doi: 10.1016/j.npep.2017.04.003. Epub 2017 Apr 6.

引用本文的文献

1
Haplotypes, Genotypes, and DNA Methylation Levels of Neuromedin U Gene Are Associated with Cardio-Metabolic Parameters: Results from the Moli-sani Study.神经降压素U基因的单倍型、基因型和DNA甲基化水平与心脏代谢参数相关:莫利萨尼研究结果
Biomedicines. 2025 Aug 5;13(8):1906. doi: 10.3390/biomedicines13081906.
2
Duodenal neuroendocrine cells and neuromedin U in subjects with obesity: Relationship with type 2 diabetes and glucose homeostasis.肥胖受试者的十二指肠神经内分泌细胞与神经降压素U:与2型糖尿病及葡萄糖稳态的关系。
Physiol Rep. 2025 Aug;13(15):e70489. doi: 10.14814/phy2.70489.
3
Neuromedin U Deficiency Disrupts Daily Testosterone Fluctuation and Reduces Wheel-Running Activity in Rats.

本文引用的文献

1
Obesity-induced inflammation: The impact of the hematopoietic stem cell niche.肥胖引起的炎症:造血干细胞龛的影响。
JCI Insight. 2021 Feb 8;6(3):145295. doi: 10.1172/jci.insight.145295.
2
Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction.严重肥胖对射血分数保留心力衰竭患者运动表现的影响。
Physiol Rep. 2020 Nov;8(22):e14634. doi: 10.14814/phy2.14634.
3
Obesity and asthma.肥胖与哮喘。
神经介素U缺乏会破坏大鼠的每日睾酮波动并降低其转轮活动。
Endocrinology. 2025 Jun 10;166(8). doi: 10.1210/endocr/bqaf102.
4
Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancer.神经介素U受体1缺失导致结直肠癌免疫治疗反应受损和高恶性程度。
iScience. 2024 Jun 20;27(7):110318. doi: 10.1016/j.isci.2024.110318. eCollection 2024 Jul 19.
5
Limostatin and Its Human Ortholog Promote West Nile Virus Infection.抑食素及其人类同源物促进西尼罗河病毒感染。
Insects. 2024 Jun 12;15(6):446. doi: 10.3390/insects15060446.
6
Discovery of a Pentapeptide Antagonist to Human Neuromedin U Receptor 1.人神经介素U受体1五肽拮抗剂的发现。
ACS Med Chem Lett. 2024 May 24;15(6):885-891. doi: 10.1021/acsmedchemlett.4c00091. eCollection 2024 Jun 13.
7
The association of Neuromedin U levels and non-alcoholic fatty liver disease: A comparative analysis.神经介素U水平与非酒精性脂肪性肝病的关联:一项对比分析。
Heliyon. 2024 Mar 5;10(5):e27291. doi: 10.1016/j.heliyon.2024.e27291. eCollection 2024 Mar 15.
8
Neuromedin U regulates the anti-tumor activity of CD8 T cells and glycolysis of tumor cells in the tumor microenvironment of pancreatic ductal adenocarcinoma in an NMUR1-dependent manner.神经调节素 U 通过 NMUR1 依赖的方式调节胰腺导管腺癌肿瘤微环境中 CD8 T 细胞的抗肿瘤活性和肿瘤细胞的糖酵解。
Cancer Sci. 2024 Feb;115(2):334-346. doi: 10.1111/cas.16024. Epub 2023 Dec 10.
9
Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer.鉴定和验证 8 个与雌激素相关的基因,用于预测甲状腺乳头状癌的预后。
Aging (Albany NY). 2023 Mar 13;15(5):1668-1684. doi: 10.18632/aging.204582.
10
Expression of , and in colon cancer and their influences on prognosis.[具体基因名称]、[具体基因名称]和[具体基因名称]在结肠癌中的表达及其对预后的影响。 (你提供的原文中基因名称缺失,我按格式补充了相关内容以便理解)
Transl Cancer Res. 2022 Oct;11(10):3572-3583. doi: 10.21037/tcr-22-1377.
J Allergy Clin Immunol. 2020 Oct;146(4):685-693. doi: 10.1016/j.jaci.2020.08.011.
4
Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade.非酒精性脂肪性肝病的多重平行打击假说:十年后再审视
Hepatology. 2021 Feb;73(2):833-842. doi: 10.1002/hep.31518. Epub 2021 Feb 6.
5
Cocaine has some effect on neuromedin U expressing neurons related to the brain reward system.可卡因对与大脑奖赏系统相关的神经介素U表达神经元有一定影响。
Heliyon. 2020 May 19;6(5):e03947. doi: 10.1016/j.heliyon.2020.e03947. eCollection 2020 May.
6
A chemically stable peptide agonist to neuromedin U receptor type 2.一种化学稳定的神经调节素 U 受体 2 型肽激动剂。
Bioorg Med Chem. 2020 May 15;28(10):115454. doi: 10.1016/j.bmc.2020.115454. Epub 2020 Mar 22.
7
Transnasal Delivery of the Peptide Agonist Specific to Neuromedin-U Receptor 2 to the Brain for the Treatment of Obesity.经鼻给予神经降压素 U 受体 2 肽激动剂以治疗肥胖症的脑内递送。
Mol Pharm. 2020 Jan 6;17(1):32-39. doi: 10.1021/acs.molpharmaceut.9b00571. Epub 2019 Dec 9.
8
Neuromedin U suppresses prolactin secretion via dopamine neurons of the arcuate nucleus.神经钙黏素 U 通过弓状核的多巴胺神经元抑制催乳素分泌。
Biochem Biophys Res Commun. 2020 Jan 8;521(2):521-526. doi: 10.1016/j.bbrc.2019.10.156. Epub 2019 Oct 31.
9
Comparison of glucose tolerance between wild-type mice and mice with double knockout of neuromedin U and neuromedin S.野生型小鼠与神经介素U和神经介素S双敲除小鼠的葡萄糖耐量比较。
J Vet Med Sci. 2019 Sep 18;81(9):1305-1312. doi: 10.1292/jvms.19-0320. Epub 2019 Jul 25.
10
Brain region-specific neuromedin U signalling regulates alcohol-related behaviours and food intake in rodents.脑区特异性神经调节素 U 信号调节啮齿动物的酒精相关行为和食物摄入。
Addict Biol. 2020 May;25(3):e12764. doi: 10.1111/adb.12764. Epub 2019 May 8.